BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hauser P, Kern S. Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications. World J Hepatol 2015; 7(15): 1921-1935 [PMID: 26244067 DOI: 10.4254/wjh.v7.i15.1921]
URL: https://www.wjgnet.com/1948-5182/full/v7/i15/1921.htm
Number Citing Articles
1
Irene Pericot-Valverde, Moonseong Heo, Jiajing Niu, Lior Rennert, Brianna L. Norton, Matthew J. Akiyama, Julia Arnsten, Alain H. Litwin. Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorderDrug and Alcohol Dependence 2022; 234: 109403 doi: 10.1016/j.drugalcdep.2022.109403
2
David Back, Pamela Belperio, Mark Bondin, Francesco Negro, Andrew H. Talal, Caroline Park, ZhenZhen Zhang, Brett Pinsky, Eric Crown, Federico J. Mensa, Fiona Marra. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysisJournal of Viral Hepatitis 2019; 26(8): 951 doi: 10.1111/jvh.13110
3
Ellen C. Caniglia, Maria Khan, Kaoon Ban, R. Scott Braithwaite. Integrating Screening and Treatment of Unhealthy Alcohol Use and Depression with Screening and Treatment of Anxiety, Pain, and Other Substance Use Among People with HIV and Other High-Risk PersonsAIDS and Behavior 2021; 25(S3): 339 doi: 10.1007/s10461-021-03245-5
4
Peter Hauser. Hepatitis C and Psychiatric and Substance Use Disorders Co-morbidities; Caring for People with Hepatitis C: Lessons from the Past that Inform Expectations in the FutureOpen Medicine Journal 2016; 3(1): 49 doi: 10.2174/1874220301603010049
5
Mawuena Binka, Sofia Bartlett, Héctor A. Velásquez García, Maryam Darvishian, Dahn Jeong, Prince Adu, Maria Alvarez, Stanley Wong, Amanda Yu, Hasina Samji, Mel Krajden, Jason Wong, Naveed Z. Janjua. Impact of COVID‐19‐related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysisLiver International 2021; 41(12): 2849 doi: 10.1111/liv.15074
6
Elizabeth Le, Grace Chee, Miki Kwan, Ramsey Cheung. Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C TreatmentDigestive Diseases and Sciences 2022; 67(4): 1244 doi: 10.1007/s10620-021-06941-3
7
Luis Margusino‐Framiñán, Eva Bobadilla‐Pérez, Purificación Cid‐Silva, Alejandro Rodríguez‐Sotelo, Juan C. Yáñez‐Rubal, Álvaro Mena‐de‐Cea, Francisco Suárez‐López, Andrea Prieto‐Pérez, Víctor Giménez‐Arufe, Manuel Delgado‐Blanco, Ana I. Sanclaudio‐Luhia, Isabel Martín‐Herranz, Ángeles Castro‐Iglesias. Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practiceJournal of Medical Virology 2020; 92(12): 3488 doi: 10.1002/jmv.25772
8
Hiroshi Okano, Takanori Takenaka, Hiroki Asakawa, Satomi Tsuruga, Hiroaki Kumazawa, Yoshiaki Isono, Hiroki Tanaka, Shimpei Matsusaki, Tomohiro Sase, Tomonori Saito, Katsumi Mukai, Akira Nishimura. Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disordersExperimental and Therapeutic Medicine 2023; 26(2) doi: 10.3892/etm.2023.12100
9
Elizabeth Chereji, Shira Kern, Bret Fuller, Benjamin J. Morasco, Alissa Phelps, Peter Hauser. Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis COpen Medicine Journal 2016; 3(1): 79 doi: 10.2174/1874220301603010079
10
Jonathan Shuter, Alain H. Litwin, Mark S. Sulkowski, Addi Feinstein, Avram Bursky-Tammam, Stephen Maslak, Andrea H. Weinberger, Hannah Esan, Kate S. Segal, Brianna Norton. Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis CNicotine & Tobacco Research 2016; : ntw212 doi: 10.1093/ntr/ntw212
11
K.S. Hong, N.R. Kim, S.H. Song, G. Hong. Cycling of Dexmedetomidine May Prevent Delirium After Liver TransplantationTransplantation Proceedings 2018; 50(4): 1080 doi: 10.1016/j.transproceed.2017.11.076